Incidences of malignant neoplasms were low and stable with long-term ixekizumab treatment for people with psoriatic disease ...

We interviewed experts in the field of pediatric rheumatology to understand gaps in juvenile idiopathic arthritis management.

“While the phase 3 results of GCAptAIN did not replicate the positive outcomes observed in the phase 2 trial, we remain committed to continuing to drive scientific progress and deepening the ...

A new preclinical study from scientists at Scripps Research suggests that an existing drug, already approved for treating ...